Skip to main content
The Actuary: The magazine of the Institute and Faculty of Actuaries - return to the homepage Logo of The Actuary website
  • Search
  • Visit The Actuary Magazine on Facebook
  • Visit The Actuary Magazine on LinkedIn
  • Visit @TheActuaryMag on Twitter
Visit the website of the Institute and Faculty of Actuaries Logo of the Institute and Faculty of Actuaries

Main navigation

  • News
  • Features
    • General Features
    • Interviews
    • Students
    • Opinion
  • Topics
  • Knowledge
    • Business Skills
    • Careers
    • Events
    • Predictions by The Actuary
    • Whitepapers
  • Jobs
  • IFoA
    • CEO Comment
    • IFoA News
    • People & Social News
    • President Comment
  • Archive

Topics

  • Data Science
  • Investment
  • Risk & ERM
  • Pensions
  • Environment
  • Soft skills
  • General Insurance
  • Regulation Standards
  • Health care
  • Technology
  • Reinsurance
  • Global
  • Life insurance
Quick links:
  • Home
  • The Actuary Issues
  • November 2020
IFoA News
News

Longevity Bulletin: The pharmacology issue

Open-access content 4th November 2020

The extraordinary events of 2020 have shown us how much we rely on epidemiology and pharmacology.

Longevity Bulletin: The pharmacology issue

Epidemiology helped quantify and model the spread of the pandemic and its mortality impact, while pharmacology offers us tests and, we hope soon, a vaccine. 

Issue 12 of the IFoA’s Longevity Bulletin explores the topic of pharmacology from a number of different perspectives. examining:

  •  Whether the prescribing of too many medications is actually having a detrimental effect on health, and why the current system encourages over-prescribing
  •  The growth of epidemiology as a research area since the 1950s, looking at how it moved away from the medical field into academia, and why results from medical trials may not always be as robust as imagined
  •  The opioid epidemic in the UK and the US, and the steps being taken to try to mitigate it
  •  The role of pharmacology in the treatment of diabetes and high cholesterol, and the impact of the statins used to treat high cholesterol on the incidence of diabetes.

To read the complete bulletin, please go to bit.ly/36OZbUZ

ACT Nov20_Full.jpg
This article appeared in our November 2020 issue of The Actuary.
Click here to view this issue
Filed in:
IFoA News
Also filed in:
News
Share
  • Twitter
  • Facebook
  • Linked in
  • Mail
  • Print

Latest Jobs

Bermuda - Life Insurance / Reinsurance: Pricing & Structuring

Excellent salary and bonus
Reference
120059

Senior Longevity Consultant

Greater Manchester, Manchester, England / England, London / Edinburgh, Scotland
Negotiable
Reference
120085

Nearly/Newly Qualified Risk Actuary

London (Central)
£60,000 - £75,000
Reference
120065
See all jobs »
 
 
 
 

Sign up to our newsletter

News, jobs and updates

Sign up

Subscribe to The Actuary

Receive the print edition straight to your door

Subscribe
Spread-iPad-slantB-june.png
​
FOLLOW US
The Actuary on LinkedIn
@TheActuaryMag on Twitter
Facebook: The Actuary Magazine
CONTACT US
The Actuary
Tel: (+44) 020 7880 6200
​

IFoA

About IFoA
Become an actuary
IFoA Events
About membership

Information

Privacy Policy
Terms & Conditions
Cookie Policy
Think Green

Get in touch

Contact us
Advertise with us
Subscribe to The Actuary Magazine
Contribute

The Actuary Jobs

Actuarial job search
Pensions jobs
General insurance jobs
Solvency II jobs

© 2020 The Actuary. The Actuary is published on behalf of the Institute and Faculty of Actuaries by Redactive Publishing Limited, Level 5, 78 Chamber Street, London, E1 8BL. Tel: 020 7880 6200